Delivery Order SPE2DR25D2007-SPE2DR26FM12B
Award Date 11/12/25
Potential Completion Date 11/13/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 200 MG tablets (30-count) on October 22, 2025, with completion targeted for October 23, 2025. This competitively awarded, firm fixed-price contract involves performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among qualified pharmaceutical distributors to support federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count) on June 24, 2025, with a ceiling value of $1,239.53 and firm fixed pricing. This non-competitive delivery order is expected to complete by June 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is a prescription anti-seizure medication used in the treatment of focal seizures, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.21 to AmerisourceBergen Drug Corp for XCOPRI 50-100 mg Titration Pak (28 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is an anticonvulsant medication used to treat seizure disorders, and this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count) valued at $3,536.88 under a firm fixed-price contract type. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive delivery order issued without a set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $2,566.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 MG tablets (30-count units) with an ultimate completion date of July 29, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,768.44, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded delivery order was issued on August 19, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) under a firm fixed-price contract valued at $2,152.35. The contract was competitively awarded without set-aside designation and has an ultimate completion date of November 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) with a ceiling value of $7,208.56. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive award and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 200 mg tablets (30-count units) on November 5, 2025, with a ceiling value of $1,206.27. This firm fixed-price delivery order, which is not set-aside, is to be completed by November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- AmerisourceBergen Drug Corp was awarded a delivery order for XCOPRI 150 mg tablets (30-count) valued at $4,854.08 by the Defense Logistics Agency's Medical Supply Chain on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XCOPRI is a prescription medication used in the treatment of...